Paytm and Pine Labs stand to benefit from the new UPI MDR framework, but the impact could differ sharply. Paytm has a larger absolute revenue opportunity, with analysts estimating FY28 UPI MDR revenue of up to Rs 1,160 crore, while Pine Labs could see a bigger impact on earnings and profitability.
Paytm and Pine Labs stand to benefit from the new UPI MDR framework, but the impact could differ sharply. Paytm has a larger absolute revenue opportunity, with analysts estimating FY28 UPI MDR revenue of up to Rs 1,160 crore, while Pine Labs could see a bigger impact on earnings and profitability.
<iframe src="https://hindustansphere.com/embed/cluster/ac46d451dca5729aaefe3b1b53e45a2b2ea5d0c9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="UPI MDR bonanza: Why Paytm may win bigger, but Pine Labs could gain faster"></iframe>
